BG105250A - Means for reducing apoptosis - Google Patents
Means for reducing apoptosisInfo
- Publication number
- BG105250A BG105250A BG105250A BG10525001A BG105250A BG 105250 A BG105250 A BG 105250A BG 105250 A BG105250 A BG 105250A BG 10525001 A BG10525001 A BG 10525001A BG 105250 A BG105250 A BG 105250A
- Authority
- BG
- Bulgaria
- Prior art keywords
- cells
- reducing apoptosis
- apoptosis
- reducing
- administered
- Prior art date
Links
- 230000006907 apoptotic process Effects 0.000 title abstract 2
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 210000004413 cardiac myocyte Anatomy 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000002889 endothelial cell Anatomy 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000004190 glucose uptake Effects 0.000 abstract 1
- 210000002569 neuron Anatomy 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9815871.0A GB9815871D0 (en) | 1998-07-21 | 1998-07-21 | Novel compound |
| GBGB9815872.8A GB9815872D0 (en) | 1998-07-21 | 1998-07-21 | Novel method |
| GBGB9905387.8A GB9905387D0 (en) | 1999-03-09 | 1999-03-09 | Novel method |
| PCT/GB1999/002361 WO2000004890A1 (en) | 1998-07-21 | 1999-07-21 | Use of glucose uptake enhancer for reducing apoptosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG105250A true BG105250A (en) | 2001-11-30 |
Family
ID=27269407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG105250A BG105250A (en) | 1998-07-21 | 2001-02-14 | Means for reducing apoptosis |
Country Status (25)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3073600A (en) * | 1999-01-19 | 2000-08-07 | Sankyo Company Limited | Inhibitor for nerve cell death due to glutamic acid cytotoxicity |
| ES2204684T3 (es) * | 1999-08-27 | 2004-05-01 | Eli Lilly And Company | Derivados de biaril-oxa(tia)zol y su uso como modulares de ppar. |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2137915T3 (es) * | 1987-09-04 | 2000-01-01 | Beecham Group Plc | Derivados de tiazolidindiona sustituida. |
| JPH05202042A (ja) * | 1992-01-24 | 1993-08-10 | Sankyo Co Ltd | 糖尿病性合併症治療剤 |
| GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
| NZ314406A (en) * | 1996-03-18 | 2000-12-22 | Sankyo Co | Treatment or prophylaxis of pancreatitis with a medicament containing an insulin sensitiser including oxazoles and thiazoles |
| GB9611947D0 (en) * | 1996-06-07 | 1996-08-07 | Glaxo Group Ltd | Medicaments |
| US6277819B1 (en) * | 1996-08-30 | 2001-08-21 | Eli Lilly And Company | Use of GLP-1 or analogs in treatment of myocardial infarction |
| WO1998010760A1 (fr) * | 1996-09-12 | 1998-03-19 | Sankyo Company, Limited | Potentialisateur d'activite de glutathione-reductase contenant de la troglitazone |
| GB9721692D0 (en) * | 1997-10-13 | 1997-12-10 | Smithkline Beecham Plc | Novel treatment |
| ATE325607T1 (de) * | 1997-11-19 | 2006-06-15 | Takeda Pharmaceutical | Aptoptoseinhibitoren |
| AU2781899A (en) * | 1998-02-24 | 1999-09-15 | Trustees Of The University Of Pennsylvania, The | Use of a cardiac purinoceptor to effect cellular glucose uptake |
| AU4005299A (en) * | 1998-05-19 | 1999-12-06 | Regents Of The University Of California, The | Thiazolidine and oxazolidine derivatives for the treatment of acute myocardial infarction and inhibition of cardiomyocyte apoptosis |
| US5968960A (en) * | 1999-01-14 | 1999-10-19 | The Regents Of The University Of California | Use of thiazolidinediones to ameliorate the adverse consequences of myocardial ischemia on myocardial function and metabolism |
-
1999
- 1999-07-21 CN CN99808983A patent/CN1310620A/zh active Pending
- 1999-07-21 JP JP2000560883A patent/JP2002521326A/ja active Pending
- 1999-07-21 BR BR9912117-4A patent/BR9912117A/pt not_active IP Right Cessation
- 1999-07-21 SK SK101-2001A patent/SK1012001A3/sk unknown
- 1999-07-21 EP EP04078537A patent/EP1516617A2/en not_active Withdrawn
- 1999-07-21 DK DK99934914T patent/DK1098639T3/da active
- 1999-07-21 KR KR1020017000925A patent/KR20010079551A/ko not_active Withdrawn
- 1999-07-21 TR TR2001/00207T patent/TR200100207T2/xx unknown
- 1999-07-21 CA CA002338211A patent/CA2338211A1/en not_active Abandoned
- 1999-07-21 HU HU0103199A patent/HUP0103199A3/hu unknown
- 1999-07-21 ES ES99934914T patent/ES2237929T3/es not_active Expired - Lifetime
- 1999-07-21 WO PCT/GB1999/002361 patent/WO2000004890A1/en active IP Right Grant
- 1999-07-21 SI SI9930772T patent/SI1098639T1/xx unknown
- 1999-07-21 PT PT99934914T patent/PT1098639E/pt unknown
- 1999-07-21 EP EP99934914A patent/EP1098639B1/en not_active Expired - Lifetime
- 1999-07-21 ID IDW20010150A patent/ID26986A/id unknown
- 1999-07-21 DE DE69923687T patent/DE69923687T2/de not_active Expired - Fee Related
- 1999-07-21 AP APAP/P/2001/002036A patent/AP2001002036A0/en unknown
- 1999-07-21 EA EA200100165A patent/EA200100165A1/ru unknown
- 1999-07-21 OA OA1200100010A patent/OA11579A/en unknown
- 1999-07-21 AU AU50537/99A patent/AU5053799A/en not_active Abandoned
- 1999-07-21 IL IL14066499A patent/IL140664A0/xx unknown
- 1999-07-21 AT AT99934914T patent/ATE288746T1/de not_active IP Right Cessation
- 1999-07-21 PL PL99345627A patent/PL345627A1/xx not_active Application Discontinuation
-
2001
- 2001-01-18 NO NO20010292A patent/NO20010292L/no unknown
- 2001-02-14 BG BG105250A patent/BG105250A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1516617A2 (en) | 2005-03-23 |
| TR200100207T2 (tr) | 2001-05-21 |
| HUP0103199A2 (hu) | 2002-05-29 |
| DE69923687D1 (de) | 2005-03-17 |
| NO20010292D0 (no) | 2001-01-18 |
| BR9912117A (pt) | 2001-04-10 |
| NO20010292L (no) | 2001-03-08 |
| SK1012001A3 (en) | 2001-08-06 |
| DE69923687T2 (de) | 2006-04-06 |
| ID26986A (id) | 2001-02-22 |
| PT1098639E (pt) | 2005-06-30 |
| EP1098639B1 (en) | 2005-02-09 |
| EA200100165A1 (ru) | 2001-08-27 |
| AU5053799A (en) | 2000-02-14 |
| ES2237929T3 (es) | 2005-08-01 |
| AP2001002036A0 (en) | 2001-03-31 |
| SI1098639T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2005-08-31 |
| ATE288746T1 (de) | 2005-02-15 |
| EP1098639A1 (en) | 2001-05-16 |
| OA11579A (en) | 2004-06-01 |
| PL345627A1 (en) | 2002-01-02 |
| DK1098639T3 (da) | 2005-06-13 |
| IL140664A0 (en) | 2002-02-10 |
| CN1310620A (zh) | 2001-08-29 |
| CA2338211A1 (en) | 2000-02-03 |
| JP2002521326A (ja) | 2002-07-16 |
| WO2000004890A1 (en) | 2000-02-03 |
| HK1037865A1 (en) | 2002-02-22 |
| HUP0103199A3 (en) | 2002-08-28 |
| KR20010079551A (ko) | 2001-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL341300A1 (en) | Non-dissolvable compositions for monitoring glucose level in blood | |
| OA08138A (en) | Disinfection method and composition therefor. | |
| IL124557A0 (en) | Compositions for reducing blood glucose and/or inhibiting the activity of cgrp | |
| EP0196334A4 (en) | CELL DESTRUCTION METHOD AND CELL DESTRUCTING AGENT. | |
| IL187254A (en) | ANTISENSE NUCLEOTIDES, COMPOSITIONS COMPRISING THEREOF AND THEIR USE IN MODULATING ACTIVATION OF NF-kB | |
| IL143569A0 (en) | A combination of fbpase inhibitors and insulin sensitizers for the treatment of diabetes | |
| EP0198092A4 (en) | MAGNESIUM OR MAGNESIUM ALLOY WITH TREATED SURFACE, AND METHOD FOR TREATING THEIR SURFACE. | |
| GB9311276D0 (en) | Well inserts for use in tissue culture | |
| AU4830097A (en) | Use of an extract of Cimicifuga | |
| EP0671768A3 (en) | Improvements in or regarding electrodes for LSI. | |
| AU6539000A (en) | Composition and method for treating disease by increasing activated alpha2 macroglobulin in the blood and extravascular tissue | |
| HK1042852A1 (zh) | 增强胰岛素反应的方法 | |
| MY120530A (en) | Combination preparation for use in dementia | |
| BG105250A (en) | Means for reducing apoptosis | |
| GB0210357D0 (en) | Methods for regulating blood glucose and appetite suppression in type 2 diabetics | |
| EP0621477A3 (en) | Method for obtaining a quantitative representation of the cellular morphology of a biological tissue. | |
| PL328948A1 (en) | Autism treating method | |
| GB8909428D0 (en) | Improvements in and relating to arch supporting insoles | |
| IL128966A (en) | Pharmaceutical composition containing sulodexide for treatment of diabetic retinopathy | |
| PL328924A1 (en) | Method of treating abuse of substances | |
| EP0904094A4 (en) | TREATMENT OF BONE DISEASES WITH ADRENOMEDULLIN | |
| DE69110861D1 (de) | Mittel zur verbesserung des kollagenmetabolismus und dessen verwendung. | |
| GB2302832B (en) | Improvements in or relating to metal spinning | |
| BG105251A (en) | Use of glucose uptake enhancer for reducing post-ischemic injury of the heart | |
| ZA992400B (en) | Process for hot-rolling stainless steel and surface treatment compositions used therein. |